TITLE

Valeant Selling $1.5B in HY Drive-By

AUTHOR(S)
Sheahan, Matthew
PUB. DATE
March 2011
SOURCE
High Yield Report;3/7/2011, Vol. 22 Issue 10, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article Valeant Pharmaceuticals' issuance of junk bonds worth 1.5 billion U.S. dollars to pay down debt.
ACCESSION #
59240303

 

Related Articles

  • Valeant Prices $1.2B HY Deal. Sheahan, Matthew // High Yield Report;9/27/2010, Vol. 21 Issue 39, p9 

    The article reports on a junk bond sold by Valeant Pharmaceuticals on September 21, 2010.

  • Valeant Offering $2.25B in HY. Sheahan, Matthew // High Yield Report;9/24/2012, p14 

    The article reports on a three-part junk bond offering worth 2.25 billion dollars of Valeant Pharmaceutical International.

  • Valeant Prices $1.5B in Two-Part Junk Deal. Sheahan, Matthew // High Yield Report;3/7/2011, Vol. 22 Issue 10, p15 

    The article reports on junk bonds worth 1.5 billion U.S. dollars issued by Valeant Pharmaceuticals International.

  • Valeant Sells $2.25B in Two-Part Deal. Sheahan, Matthew // High Yield Report;9/24/2012, p29 

    The article reports on the success of Valeant Pharmaceutical International to sell bonds worth 2.25 billion dollars in a two-part junk bond offering that will help fund its acquisitions.

  • Valeant Prescribes Itself $700M in HY. Sheahan, Matthew // High Yield Report;11/22/2010, Vol. 21 Issue 47, p13 

    The article reports on the plans of Canadian specialty pharmaceutical company Valeant Pharmaceuticals International to issue 700 million U.S. dollar in junk bonds to repay term loan debt.

  • Valeant Prices $1B in Upsized Bond Deal. Sheahan, Matthew // High Yield Report;11/22/2010, Vol. 21 Issue 47, p20 

    The article focuses on the one billion U.S. dollars in junk bonds issued by Valeant Pharmaceuticals International in a deal upsized from 700 million U.S. dollars on November 25, 2010.

  • Valeant Deal Has Pledge of $12B in HY. Sheahan, Matthew // High Yield Report;6/30/2014, p1 

    The article reports on the high yield bonds pledged by banks financing the acquisition by Valeant Pharmaceuticals International of health care firm Allergan in 2014. Topics covered include the value of leveraged loans received to back the deal, the launch by Valeant of a stock exchange offer for...

  • Three Companies Ready New Bonds. Kellerhals, Richard // High Yield Report;6/1/2009, Vol. 20 Issue 22, p14 

    The article reports that three companies are preparing their respective high yield bond issues amounting to 1 billion U.S. dollars. Tenneco will be issuing senior unsecured notes totaling 500 million U.S. dollars. Valeant Pharmaceuticals is planning to use proceeds to repurchase debt and for...

  • Issuers Price Nearly $7B in HY. Sheahan, Matthew // High Yield Report;9/24/2012, p31 

    The article reports on the success of ten companies to sell 6.725 billion dollars worth of new issues on the junk bond market on September 23, 2012. Valeant Pharmaceutical International was able to sell 2.25 billion dollars in a two-part deal. Ford Motor successfully sold 1 billion dollars in...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics